#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Gestational trophoblastic tumour Becker's muscular dystrophy Arterial tortuosity syndrome Paraganglion neoplasm Leukodystrophy Pleomorphic leiomyosarcoma HER2 mutant non-small cell lung cancer Hereditary neuropathic amyloidosis Anaplastic large cell lymphoma T- and null-cell types Leukaemia Oesophageal carcinoma Advanced systemic mastocytosis Hereditary hypophosphataemic rickets Acquired ATTR amyloidosis Hyperadrenocorticism More trials…

    Learn about Rare Diseases

    Wolfram syndrome – Basic Information X-linked lymphoproliferative syndrome – Treatment Extranodal marginal zone B-cell lymphoma (MALT type) – Diagnostics SAPHO syndrome – Treatment Rett syndrome – Treatment Rhabdomyosarcoma recurrent – Diagnostics Pleomorphic leiomyosarcoma Malignant fibrous histiocytoma – Trials in Disease Focal segmental glomerulosclerosis – Trials in Disease Castleman’s disease – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    PETHIDINE HYDROCHLORIDE Rmc-6291 PICLIDENOSON Azd8630 Promazine Hydrochloride Pregabalin Ivabradine Hydrochloride Oxymetazoline Hydrochloride Betula Alba Pollen Extract Melphalan Flufenamide Hydroxypropylbetadex Levobupivacaine Hydrochloride Mk-1084 Rosuvastatin Vosoritide Alteplase Bedaquiline Caffeine Tamibarotene Mitoxantrone Hydrochloride More therapies…

    Learn about Your Condition

    Hyponatraemia Endometrial cancer stage IV Factor VIII deficiency Crohn's disease Diabetes mellitus Appendicitis perforated Major depression Radius fracture Pancreaticoduodenectomy Anogenital warts Renal cancer Breast conserving surgery Anal squamous cell carcinoma Cortisol abnormal Low cardiac output syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Dexamethasone and Sodium Chloride for Treating Severe Hospital-Acquired Pneumonia in Critically Ill Patients with a Proinflammatory Profile

    Recruiting

    3 1 1
    Investigated Diseases:
    • Pneumonia
    Investigated Drugs:
    • Dexamethasone Phosphate
    • Sodium Chloride
    Belgium France Greece Spain

  • Study on C1 Esterase Inhibitor for Treating and Preventing Hereditary Angioedema Attacks in Patients with C1-INH Deficiency

    Recruiting

    3 1 1
    Investigated Drugs:
    • C1 Esterase Inhibitor (Human)
    • Sodium Chloride
    Bulgaria Romania

  • Study on Acyclovir for Patients with Herpes Simplex Virus Reactivation in the Throat on Mechanical Ventilation with One or No Organ Failure

    Recruiting

    3 1 1
    Investigated Diseases:
    • Herpes simplex reactivation
    Investigated Drugs:
    • Aciclovir
    • Sodium Chloride
    France

  • Study Comparing Avatrombopag and Rituximab for Adults with Immune Thrombocytopenia Not Responding to Corticosteroids

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Avatrombopag
    • Rituximab
    Norway

  • Study on Pain Relief After Obesity Surgery Using Esketamine, Dexmedetomidine, and Lidocaine Hydrochloride Monohydrate for Patients Undergoing Obesity Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Procedural pain
    • Obesity
    Investigated Drugs:
    • Remifentanil Hydrochloride
    • Dexmedetomidine
    • Esketamine
    Sweden

  • Study on the Long-term Safety of Efgartigimod for Children with Generalized Myasthenia Gravis

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Efgartigimod Alfa
    Austria Belgium Czechia France Germany Italy +3
Previous Page
1 … 430 431 432 433 434 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!